Oct 30

WHISTLEBLOWER ACTION FOR YOU?

AmerisourceBergen Corporation Agrees to Pay $625 Million to Resolve Allegations That it Illegally Repackaged Cancer–Supportive Injectable Drugs to Profit From Overfill

I am very pleased that a couple of my clients were among the successful relators in a whistleblower action that is among the tenth largest in U.S. history.

I remember the day when my client-pharmacists came to my office telling me about an elaborate scheme. They had knowledge that expensive cancer drugs were removed from their original packaging, then re-packaged into prefilled syringes; essentially creating a fifth dose of the medication from the overfill from four legitimate dosage units.

This allowed AmerisourceBergen and its subsidiary to bill government for adulterated and misbranded medications.

The settlement with the government for this scheme was over $625 million dollars.

Never was the current phrase “if you see something, say something” more effective.

If you know about wrongdoing please first keep it secret and second, call me. In general, the first to report takes the lion’s share of the recovery–Promptness and secrecy are key.